![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](nc6013contents.gif)
Acta Cryst. (2005). E61, o154-o155 [ doi:10.1107/S1600536804033100 ]
Abstract: The title compound [systematic name: (
)-5-({4-[2-(5-ethyl-2-pyridinio)ethoxy]phenyl}methyl)thiazolidine-2,4-dione chloride], C19H21N2O3S+·Cl-, is an oral antidiabetic agent. In the crystal structure, the molecules are linked by N-H
Cl hydrogen bonds into chains.
Online 24 December 2004
Copyright © International Union of Crystallography
IUCr Webmaster